Results 301 to 310 of about 8,017,739 (402)
Trends of Coverage of Mass Drug Administration, Population at Risk and Reported Cases of Schistosomiasis and Soil-Transmitted Helminths, Uganda, 2013-2023. [PDF]
Namara BG+6 more
europepmc +1 more source
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung+6 more
wiley +1 more source
A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics. [PDF]
Watson JR+11 more
europepmc +1 more source
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim+18 more
wiley +1 more source
Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Background Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical. Therefore, we analyzed data from our
Shivani Garg+9 more
wiley +1 more source
Enhancing drug administration in <i>Drosophila melanogaster</i>: a method for using solid dispersions for improved solubility and bioavailability. [PDF]
Cheku S+3 more
europepmc +1 more source
Barack Obama Administration and the “war on drugs”: more continuity than change
Lívia Peres Milani
openalex